Ex­clu­sive: Af­ter Turn­ing Point suc­cess, on­col­o­gy vets in-li­cense first as­set for Aven­zo Ther­a­peu­tics

Athena Coun­tou­ri­o­tis and her for­mer col­leagues at Turn­ing Point Ther­a­peu­tics have in-li­censed their first on­col­o­gy as­set at their next ven­ture, Aven­zo Ther­a­peu­tics, which is on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.